Appalto specifico per la fornitura PER CONTINUITA’ TERAPEUTICA del farmaco BERINERT PROTEINA DEL PLASMA UMANO ANTIANGIOEDEMA SOLUZIONE INIETT POLV SOLV 500 UI

different companies won its awards

30

of the awards went to the three most frequent winners

28%

of its calls state an estimated value

52%

Based on 39 awards with a named winner over the last 3 years. Counted by award, not by value, because lot and framework amounts are not comparable. Concentrated means the three most frequent winners took 65% or more of the awards; many suppliers, under 35% with at least ten different winners.

Competition

of the awards went to companies based in another country

0%

As the official award notices state them, over the last 3 years. Tenders per lot count open and restricted procedures only: in a negotiated procedure or a direct award a single tender is the procedure itself. The country is the one the notice gives for the winner.

Italy · Medical equipment & pharmaceuticals

different companies won awards here

1,685

of the awards went to the three most frequent winners

3%

winners of the last 12 months were new here

1,383 of 1,448

buyers awarded contracts here

390

Based on 2,636 awards with a named winner over the last 3 years. Counted by award, not by value, because lot and framework amounts are not comparable. Concentrated means the three most frequent winners took 65% or more of the awards; many suppliers, under 35% with at least ten different winners. New: no award from the same buyer or market in the two years before.

Competition

tenders per lot on average (open and restricted procedures)

1.9

of those lots received a single tender

37%

of the awards went to companies based in another country

1%

of the tenders came from another country

12%

As the official award notices state them, over the last 3 years. Tenders per lot count open and restricted procedures only: in a negotiated procedure or a direct award a single tender is the procedure itself. The country is the one the notice gives for the winner.